166 related articles for article (PubMed ID: 7843263)
1. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
Felsch A; Stöcker K; Borchard U
Eur J Pharmacol; 1994 Oct; 263(3):261-8. PubMed ID: 7843263
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes.
Stein B; Schmitz W; Scholz H; Seeland C
J Mol Cell Cardiol; 1994 Mar; 26(3):403-14. PubMed ID: 8028023
[TBL] [Abstract][Full Text] [Related]
3. Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes.
Behnke N; Müller W; Neumann J; Schmitz W; Scholz H; Stein B
J Pharmacol Exp Ther; 1990 Sep; 254(3):1017-23. PubMed ID: 2168481
[TBL] [Abstract][Full Text] [Related]
4. Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO.
Maddock HL; Broadley KJ; Bril A; Khandoudi N
J Pharm Pharmacol; 2002 Jun; 54(6):859-67. PubMed ID: 12079003
[TBL] [Abstract][Full Text] [Related]
5. Adenosine receptor-mediated alterations in prostacyclin production and cardiac function in the isolated rabbit heart.
Cano C; Malik KU
J Pharmacol Exp Ther; 1992 May; 261(2):660-8. PubMed ID: 1578377
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A(2A) receptors.
Maddock HL; Broadley KJ; Bril A; Khandoudi N
J Auton Pharmacol; 2001; 21(5-6):263-71. PubMed ID: 12123472
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
Lozza G; Conti A; Ongini E; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
Li Jm; Fenton RA; Wheeler HB; Powell CC; Peyton BD; Cutler BS; Dobson JG
J Surg Res; 1998 Dec; 80(2):357-64. PubMed ID: 9878338
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
[TBL] [Abstract][Full Text] [Related]
10. A2A-adenosine receptor reserve for coronary vasodilation.
Shryock JC; Snowdy S; Baraldi PG; Cacciari B; Spalluto G; Monopoli A; Ongini E; Baker SP; Belardinelli L
Circulation; 1998 Aug; 98(7):711-8. PubMed ID: 9715864
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors.
Bryan PT; Marshall JM
J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):151-62. PubMed ID: 9831723
[TBL] [Abstract][Full Text] [Related]
13. The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.
Amoroso S; Iannotti E; Saggese ML; Di Renzo G; Annunziato L
Biochim Biophys Acta; 1995 Oct; 1239(1):67-73. PubMed ID: 7548146
[TBL] [Abstract][Full Text] [Related]
14. Augmented release of serotonin by adenosine A2a receptor activation and desensitization by CGS 21680 in the rat nucleus tractus solitarius.
Barraco RA; Helfman CC; Anderson GF
Brain Res; 1996 Sep; 733(2):155-61. PubMed ID: 8891297
[TBL] [Abstract][Full Text] [Related]
15. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
16. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
17. Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.
Hiley CR; Bottrill FE; Warnock J; Richardson PJ
Br J Pharmacol; 1995 Nov; 116(6):2641-6. PubMed ID: 8590983
[TBL] [Abstract][Full Text] [Related]
18. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
19. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E
Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neurotransmitter release from enteric nerve endings by 2-[p-(carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamido-adenosine (CGS-21680) and related adenosine analogs: lack of simple competition by antagonists.
Broad RM; Cook MA
J Pharmacol Exp Ther; 1993 Aug; 266(2):634-41. PubMed ID: 8102645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
